Research into community pharmacists' role in treating breast cancer funded
Pharmacy Research UK has awarded grants for research projects on topics ranging from deprescribing in hospital to the targeting of inhaled corticosteroids in chronic obstructive pulmonary disease.
How community pharmacists could play a greater role in treating breast cancer is one of five research projects awarded funding by Pharmacy Research UK (PRUK).
Almost £85,000 has been given to support pharmacy research by PRUK this year. Research training bursaries are designed to support pharmacists early in their career to develop skills and conduct research relating to their practice.
Personal research fellowships are intended to develop pharmacy practice research capacity.
Lydia Tutt, from the University of Nottingham, was awarded a training bursary of more than £10,000 for her research into the role of the community pharmacist in breast cancer services, and Victoria Tavares, from the University of Manchester, received a training bursary of £9,000 for her masters in clinical research.
Research fellowship recipients
Research fellowship awards were given to: Kimberley Sonnex of the University of Nottingham, for her work on better targeting of inhaled corticosteroids in chronic obstructive pulmonary disease; Sion Scott, from the University of East Anglia, for his research into developing a model for deprescribing in hospital; and Yeyenta Osasu, of the University of Sheffield, was given the biggest award, of almost £30,000, for her research into the prescribing, consumption and monitoring of direct oral anticoagulants in elderly patients with atrial fibrillation.
Rachel Joynes, executive director at PRUK, said she was “thrilled with the breadth, depth and quality of applications”.
“We look forward to seeing the outcomes of these projects and the valuable impact that they will have on medicines optimisation and patient care,” she said.
Applications for the 2018 round of funding awards and bursaries will open in early January 2018 and close on 2 May 2018.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203990
Recommended from Pharmaceutical Press